Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Franklin Strategic Biotechnology: (MF: FBDIX)

(MF) As of Nov 20, 2014 06:05 PM ET

 Add to portfolio

$167.90 USD

+0.74 (0.44%)

Zacks MF Rank : 2 - Buy [?]   2      

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Oct 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Oct 31, 2014) 30.12
Objective Sector - Health
Peer HL MG

Zacks Premium Research for FBDIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Buy 2
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 32.46
Net Assets (Mil $) 10/31/2014 1,141.89
%Turnover 10/31/2014 48.70

Allocation

% of Portfolio
Large Growth 38.48
Large Value 0.00
Small Growth 26.22
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 10/31/2014 % of Portfolio
Health 52.41
Services 21.49
Other 13.03
Industrial Cyclical 8.93
Technology 3.42
Retail Trade 0.53
Non-Durable 0.19

Portfolio Holdings

Top Equity Holdings
(As of 7/31/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 9.66 138.83
CELGENE CORP 8.56 122.93
BIOGEN IDEC INC 8.02 115.18
AMGEN INC 5.38 77.33
MEDIVATION INC 4.59 65.91
PUMA BIOTECHNOLOGY INC 3.90 56.04
REGENERON PHARMACEUTICALS 3.45 49.62
ILLUMINA INC 2.98 42.84
ALEXION PHARMACEUTICALS I 2.81 40.34

Stock Holding % of Net Assets

As Of 7/31/2014
Total Issues 105
Avg. P/E 44.83
Avg. P/Book 6.18
Avg. EPS Growth 15.12
Avg. Market Value (Mil $) 43,295

Risk

3 Year 5 Year 10 Year
Beta 1.07 0.97 0.81
Alpha 20.41 14.41 8.97
R Squared 0.22 0.40 0.37
Std. Dev. 20.73 20.19 19.73
Sharpe 2.22 1.67 2.00